药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Zuclopenthixol
Luspatercept
The risk or severity of adverse effects can be increased when Luspatercept is combined with Trastuzumab deruxtecan.
Zuclopenthixol
Aducanumab
The risk or severity of adverse effects can be increased when Aducanumab is combined with Trastuzumab deruxtecan.
Zuclopenthixol
Ascrinvacumab
The risk or severity of adverse effects can be increased when Ascrinvacumab is combined with Trastuzumab deruxtecan.
Zuclopenthixol
Cixutumumab
The risk or severity of adverse effects can be increased when Cixutumumab is combined with Trastuzumab deruxtecan.
Zuclopenthixol
Inclacumab
The risk or severity of adverse effects can be increased when Inclacumab is combined with Trastuzumab deruxtecan.
Zuclopenthixol
Etaracizumab
The risk or severity of adverse effects can be increased when Etaracizumab is combined with Trastuzumab deruxtecan.
Zuclopenthixol
Ganitumab
The risk or severity of adverse effects can be increased when Ganitumab is combined with Trastuzumab deruxtecan.
Zuclopenthixol
Zalutumumab
The risk or severity of adverse effects can be increased when Zalutumumab is combined with Trastuzumab deruxtecan.
Zuclopenthixol
Etrolizumab
The risk or severity of adverse effects can be increased when Etrolizumab is combined with Trastuzumab deruxtecan.
Zuclopenthixol
Tralokinumab
The risk or severity of adverse effects can be increased when Tralokinumab is combined with Trastuzumab deruxtecan.
Zuclopenthixol
Dupilumab
The risk or severity of adverse effects can be increased when Dupilumab is combined with Trastuzumab deruxtecan.
Zuclopenthixol
Fasinumab
The risk or severity of adverse effects can be increased when Fasinumab is combined with Trastuzumab deruxtecan.
Zuclopenthixol
Simtuzumab
The risk or severity of adverse effects can be increased when Simtuzumab is combined with Trastuzumab deruxtecan.
Zuclopenthixol
Duligotuzumab
The risk or severity of adverse effects can be increased when Duligotuzumab is combined with Trastuzumab deruxtecan.
Zuclopenthixol
Gevokizumab
The risk or severity of adverse effects can be increased when Gevokizumab is combined with Trastuzumab deruxtecan.
Zuclopenthixol
Sotatercept
The risk or severity of adverse effects can be increased when Sotatercept is combined with Trastuzumab deruxtecan.
Zuclopenthixol
Tarextumab
The risk or severity of adverse effects can be increased when Tarextumab is combined with Trastuzumab deruxtecan.
Zuclopenthixol
Fulranumab
The risk or severity of adverse effects can be increased when Fulranumab is combined with Trastuzumab deruxtecan.
Zuclopenthixol
Patritumab
The risk or severity of adverse effects can be increased when Patritumab is combined with Trastuzumab deruxtecan.
Zuclopenthixol
Lorvotuzumab mertansine
The risk or severity of adverse effects can be increased when Lorvotuzumab mertansine is combined with Trastuzumab deruxtecan.